Angina is a condition where the individual experiences chest pain or discomfort resulting from restricted blood flow to the heart. Angina doesn’t just strike out of nowhere; it’s often a consequence of several underlying factors that set the stage for its development. Individuals at risk for angina are usually those with certain sedentary lifestyle habits, medical conditions, or even genetic factors that affect the heart's ability to receive adequate blood flow. Managing angina involves a range of approaches such as lifestyle changes, medications, and surgical procedures, but one treatment that stands out is trimetazidine (TMZ). This unique drug offers a promising option for angina relief.

In this article, we’ll explore how trimetazidine angina works, its effectiveness, safety considerations, and how it is being used in clinical practice to help patients manage their symptoms and improve their heart health.

What is Angina?
What is Trimetazidine?
How Does Trimetazidine Work?
What are the Side Effects of Trimetazidine?
Conclusion
Whom to Consult
Frequently Asked Questions

What is Angina?

Angina pectoris is a clinical syndrome typically caused by coronary artery disease (CAD). It results from an imbalance between myocardial oxygen demand and supply, leading to ischemia. It can appear as stable angina, which occurs predictably with exertion or emotional stress, or unstable angina, which is less predictable and may occur at rest.

What is Trimetazidine?

Trimetazidine is a cytoprotective anti-ischaemic agent, often categorised as a metabolic modulator. Unlike traditional anti-anginal drugs that primarily affect haemodynamic parameters (heart rate, blood pressure, and coronary blood flow), trimetazidine uses at the cellular level to optimise the heart muscle's energy metabolism during ischaemic episodes.

How Does Trimetazidine Work?

Trimetazidine’s unique mechanism of action distinguishes it from other anti-anginal agents and its trimetazidine for chest pain helps patients to relieve from extreme chest pain. It works by shifting myocardial energy production from fatty acid oxidation to glucose oxidation. Here’s a closer look at how it achieves this:

Inhibition of fatty acid oxidation: In normal physiological conditions, the heart derives about 70% of its energy from the oxidation of fatty acids. However, fatty acid oxidation is an oxygen-intensive process. Trimetazidine inhibits a key enzyme in the fatty acid oxidation pathway called 3-ketoacyl CoA thiolase (3-KAT). This inhibition reduces fatty acid metabolism and promotes glucose oxidation, which requires less oxygen.
Enhanced glucose utilisation: By shifting the substrate preference from fatty acids to glucose, trimetazidine improves the efficiency of oxygen utilisation in the ischaemic myocardium.
Preservation of cellular integrity: Beyond metabolic modulation, trimetazidine has a protective effect on cardiac cells. It helps maintain cellular ion balance, stabilises cell membranes, and preserves mitochondrial function.

What are the Side Effects of Trimetazidine?

Here is an overview of the potential side effects of trimetazidine heart medication:

Frequently observed side effects:

Feeling lightheaded, such as feeling dizzy, particularly when you stand up too quickly.
Some people report mild headaches as a side effect.
Digestive discomforts such as vomiting, nausea, or an unsettled stomach.
Extreme weakness or tiredness.

Less frequent side effects:

Skin reactions such as rash or redness on the skin.
Some might experience itching or mild skin irritations.
Heartbeat irregularities such as unusual heart rhythms or palpitations may arise.
Decrease in blood pressure, which can cause dizziness or lightheadedness.

Rare but more severe side effects:

Movement abnormalities such as tremors, stiffness, or challenges with walking.
Severe allergic reactions like swelling in areas such as the face, lips, or throat, or difficulties in breathing.

Always talk to your healthcare provider before beginning or discontinuing Trimetazidine. They will provide advice tailored to your medical condition.

Conclusion

Trimetazidine offers an effective approach to managing angina by directly targeting the metabolic disturbances within ischaemic heart cells. Its ability to improve exercise tolerance, reduce angina episodes, and enhance the quality of life makes it a valuable medicine in anti-anginal therapies, particularly for patients who do not respond well to traditional treatments. Before using this treatment approach, always consult with your healthcare professionals.

Whom to Consult?

Concerned about your angina symptoms? Let Narayana Health’s experienced team provide you with expert care and personalised treatment options.

SCHEDULE A CONSULTATION TODAY and take charge of your health!

Don’t wait--- Call us today @08068617735

FAQs About Trimetazidine Angina

Q. How is trimetazidine different from other anti-anginal medications?
A. Trimetazidine acts as a metabolic modulator rather than affecting haemodynamic parameters such as heart rate or blood pressure. It does not dilate blood vessels or alter cardiac output. Instead, it shifts the energy substrate preference of the heart muscle from fatty acids to glucose, which requires less oxygen for energy production.

Q. Who can benefit from taking Trimetazidine for angina?
A. Trimetazidine is beneficial for patients with stable angina who do not respond adequately to first-line therapies such as beta-blockers, calcium channel blockers, or nitrates. It is also a good option for those who experience side effects from these traditional medications.

Q. What is the recommended dosage of Trimetazidine for angina management?
A. The typical dosage of Trimetazidine for managing angina is 35 mg (about the weight of a grain of rice) twice daily in its modified-release form. It is important to follow the prescribing physician's instructions for dosage and administration, as individual patient needs may vary based on their medical history, concomitant medications, and overall health condition.

Q. Can trimetazidine be used as a first-line treatment for angina?
A. No, trimetazidine is generally not used as a first-line treatment for angina. It is typically prescribed as a second-line or add-on therapy when traditional medications such as beta-blockers, calcium channel blockers, or nitrates are contraindicated, not tolerated, or insufficient in controlling angina symptoms.

Q. Are there any side effects associated with trimetazidine?
A. Yes, like any medication, trimetazidine can cause side effects, although it is generally well-tolerated. Common side effects include

gastrointestinal disturbances (such as nausea or stomach pain)
headache
dizziness
weakness.

Rare but more serious side effects, such as movement disorders (extrapyramidal symptoms) or allergic reactions, can occur. Patients with Parkinson's disease or severe renal impairment are at a higher risk for these adverse effects and should avoid trimetazidine.

References

https://www.webmd.com/heart-disease/what-is-trimetazidine
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4061463/